MedPath

Assessment of a novel strategy to attenuate muscle mass loss during 2 weeks of bed rest

Completed
Conditions
Disuse, Immobilization, Injury
Registration Number
NL-OMON22281
Lead Sponsor
Maastricht University
Brief Summary

n/a

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
12
Inclusion Criteria

•Healthy males

•Age between 18 and 35 y

Exclusion Criteria

•Smoking

•Type 2 Diabetes Mellitus

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To assess the amount of muscle mass that is lost following 2 weeks of bed rest and whether BFR can be applied to effectively preserve muscle mass and strength during bed rest.
Secondary Outcome Measures
NameTimeMethod
To assess differences in muscle fiber cross-sectional area (CSA), satellite cell content/activation, muscle fiber vascularization, muscle protein synthesis rates between both legs (BFR vs control), muscle strength, whole-body fat mass, adipose tissue gene expression and oral glucose tolerance before and after 2 weeks of bed rest.
© Copyright 2025. All Rights Reserved by MedPath